Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cell Envision is a Taiwan-based biotechnology and diagnostics company focused on liquid biopsy, single-cell analysis, and tumor immune microenvironment monitoring for oncology applications. The company has developed proprietary platforms built around self-assembled cell arrangement (SACA), microfluidics, AI image recognition, living cell monitoring, and patient-derived organoid workflows. Its offerings are positioned for cancer diagnosis, recurrence monitoring, immunotherapy decision support, cell therapy evaluation, and companion-diagnostic or LDT-related use cases. Cell Envision also markets a one-stop solution for personalized cell therapy research and immuno-oncology development, including analysis of circulating tumor cells and circulating tumor microemboli. The company appears to be commercially active in Taiwan while remaining an early-stage private platform company rather than a traditional therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell Envision.